Skip to main content
. Author manuscript; available in PMC: 2023 Mar 15.
Published in final edited form as: Int J Radiat Oncol Biol Phys. 2021 Nov 9;112(4):986–995. doi: 10.1016/j.ijrobp.2021.10.147

Table 3.

Thoracic clinical toxicity adverse events for trial cohort*

Patients, no. (%)

Adverse event Grade 0 Grade 1 Grade 2 Grade 3
Pneumonitis 42 (62.7) 15 (22.4) 7 (10.4) 3 (4.5)
Esophagitis 7 (10.4) 27 (40.3) 28 (41.8) 5 (7.5)
Dyspnea 15 (22.4) 38 (56.7) 10 (14.9) 4 (6.0)
Cough 7 (10.4) 47 (70.1) 13 (19.4) 0 (0.0)
Fatigue 5 (7.5) 48 (71.6) 12 (17.9) 2 (3.0)
*

The number and percentage of patients are reported for each adverse event and toxicity grade. The data are given for each particular grade of event rather than the number of events with a given grade or higher.